| Product NDC: | 65977-5038 |
| Proprietary Name: | Levetiracetam |
| Non Proprietary Name: | Levetiracetam |
| Active Ingredient(s): | 750 mg/1 & nbsp; Levetiracetam |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, FILM COATED |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 65977-5038 |
| Labeler Name: | Hetero Drugs Ltd., |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA090515 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20101008 |
| Package NDC: | 65977-5038-2 |
| Package Description: | 120 TABLET, FILM COATED in 1 BOTTLE (65977-5038-2) |
| NDC Code | 65977-5038-2 |
| Proprietary Name | Levetiracetam |
| Package Description | 120 TABLET, FILM COATED in 1 BOTTLE (65977-5038-2) |
| Product NDC | 65977-5038 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Levetiracetam |
| Dosage Form Name | TABLET, FILM COATED |
| Route Name | ORAL |
| Start Marketing Date | 20101008 |
| Marketing Category Name | ANDA |
| Labeler Name | Hetero Drugs Ltd., |
| Substance Name | LEVETIRACETAM |
| Strength Number | 750 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Anti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE] |